• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Siemens Healthineers and RadNet's Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

    12/1/24 12:00:00 PM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    • Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operational efficiency in ultrasound.
    • The collaboration aims to facilitate remote operations, collaboration, and enhanced interpretation capabilities for increased diagnostic accuracy and consistency by combining Siemens Healthineers' Acuson Sequoia with RadNet's DeepHealth SmartSonography™.
    • A live demonstration of the technology will be held Tuesday, December 3, 10:00 AM – 10:30 AM CT at Booth #2529, South Hall, Level 3 at RSNA 2024, Chicago, IL.

    LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ:RDNT), today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware. The collaboration will combine Siemens Healthineers' Acuson Sequoia ultrasound system, RadNet's expertise in high-volume outpatient care, and DeepHealth's SmartSonography™ solution powered by the cloud-native DeepHealth OS to tackle workflow and workforce challenges for enhanced operational efficiency and better patient experience.

    High-volume ultrasound care settings face significant challenges, including workforce shortages, operator limitations and fatigue, and variability in image acquisition quality—factors that can impede timely and accurate diagnoses while contributing to unnecessary examinations. To tackle these challenges, a remote collaboration and image acquisition command center will enable experienced technologists to oversee image acquisition across multiple locations. In addition, enhanced enterprise viewer capabilities are intended to enable radiologists to review video capture of exams alongside standard ultrasound static images for a more comprehensive assessment, potentially improving diagnostic accuracy and reducing unnecessary rescans. This approach could significantly enhance access to higher-quality care and reduce patient recall rates.

    "Ultrasound has long been plagued with challenges related to lack of standardization and variability among users, and this is only compounded with the global workforce shortage," said Ajay Gannerkote, global head of ultrasound for Siemens Healthineers. "Siemens Healthineers focuses on practical AI, to make ultrasound smarter, faster, easier and more accessible. By collaborating with DeepHealth we can develop smarter ultrasound solutions that help improve productivity and access to high-quality imaging for more people."

    "We are excited to collaborate with Siemens Healthineers to redefine the landscape of ultrasound diagnostics through SmartTechnology™," said Kees Wesdorp, President and CEO of RadNet's Digital Health segment. "By integrating our AI-powered SmartSonography™ solution with Siemens Healthineers' industry-leading ultrasound systems, we aim to enhance operational efficiency and empower healthcare professionals to deliver more accurate and timely patient care. This collaboration exemplifies our commitment to leveraging advanced technology to empower breakthroughs in care through imaging for both providers and patients."

    SmartSonography™ is designed to include: 1) a remote-acquisition platform that will enable real-time scanning, assistance, training, monitoring, and protocol standardization across an imaging fleet from a single interface, intending to facilitate seamless collaboration and resource scaling in complex healthcare environments, efficient patient management and enhanced clinical confidence; 2) a cloud-native enterprise viewer accessible from anywhere that will combine essential Picture Archive and Communication Systems (PACS) functionality with cloud-native technology for fast image streaming and seamless access to data with the aim to increase diagnostic accuracy and consistency.

    Siemens Healthineers harnesses AI to make ultrasound exams faster, smarter and more accessible to healthcare settings worldwide, including underserved areas. Siemens Healthineers has recently refreshed its Ultrasound portfolio and has a fleet of systems that are designed with AI and future development in mind. The company is focused on cardiology, including leadership in interventional cardiology, and adiology/general imaging with unique offerings for liver, breast, vascular and MSK. On December 1, 2024, the Acuson Sequoia 3.5 was introduced with a first-of-its-kind AI Abdomen feature that automatically labels and measures organs in milliseconds to improve standardization, and brings new capabilities in breast and MSK imaging.

    Together, Siemens Healthineers and DeepHealth are committed to exploring next-generation ultrasound solutions that would enhance the diagnostic process, dramatically reduce scan time and operator-dependant variability, and enable better patient care.

    For more information, visit the Siemens Healthineers (#2529) and DeepHealth (#1340) booths at the Radiological Society of North America 2024 Annual Meeting, which will be held between 1 and 5 December in Chicago, U.S.A. A live demonstration of the technology will be held Tuesday, December 3, 10AM – 10:30AM CT at Booth #2529, South Hall, Level 3.

    About Siemens Healthineers

    Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.

    About RadNet, Inc.

    RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 399 owned and/or operated outpatient imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 10,000 employees. For more information, visit http://www.radnet.com.

    About DeepHealth

    DeepHealth is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ:RDNT) and serves as the umbrella brand for all companies within RadNet's Digital Health segment. DeepHealth provides AI-powered health informatics with the aim of empowering breakthroughs in care through imaging. Building on the strengths of the companies it has integrated and is rebranding (i.e., eRAD Radiology Information and Image Management Systems and Picture Archiving and Communication System, Aidence lung AI, DeepHealth and Kheiron breast AI and Quantib prostate and brain AI), DeepHealth leverages advanced AI for operational efficiency and improved clinical outcomes in lung, breast, prostate, and brain health. At the heart of DeepHealth's portfolio is a cloud-native operating system - DeepHealth OS - that unifies data across the clinical and operational workflow and personalizes AI-powered workspaces for everyone in the radiology continuum. Thousands of radiologists at hundreds of imaging centers and radiology departments around the world use DeepHealth solutions to enable earlier, more reliable, and more efficient disease detection, including in large-scale cancer screening programs. DeepHealth's human-centered, intuitive technology aims to push the boundaries of what's possible in healthcare. https://deephealth.com/

    Forward Looking Statement

    This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements, including statements regarding the capabilities of RadNet, Siemens Healthineers, and DeepHealth's informatics, hardware and software product portfolios and the collaboration's impact on radiology practices and healthcare workflow, are expressions of our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods.

    Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.

    For media inquiries, reach out to:



    Siemens Healthineers

    Bailey Allen

    Media Relations Manager

    Phone: +1 610.545.9327

    Email: [email protected]

    DeepHealth

    Andra Axente

    Communications Director

    Phone: +31 614 440971

    Email: [email protected]

    RadNet, Inc.

    Mark Stolper

    Executive Vice President and Chief Financial Officer

    310-445-2800



    Primary Logo

    Get the next $RDNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is the purpose of the collaboration between Siemens Healthineers and DeepHealth?

      Siemens Healthineers and DeepHealth are collaborating to create AI-powered SmartTechnology to enhance patient experiences and operational efficiency in ultrasound.

    • How will Siemens Healthineers and DeepHealth's collaboration enhance ultrasound operations?

      The collaboration aims to integrate Siemens Healthineers' Acuson Sequoia ultrasound system with DeepHealth's SmartSonography solution to improve diagnostic accuracy and consistency in ultrasound imaging.

    • When and where will the technology demonstration by Siemens Healthineers and DeepHealth occur?

      A live demonstration of the new AI-powered technology will take place on December 3, 2024, at Booth #2529 during the RSNA 2024 event in Chicago.

    • What challenges are Siemens Healthineers and DeepHealth addressing with their new technology?

      The collaboration intends to address challenges in high-volume ultrasound care settings, including workforce shortages and variability in image quality, by enabling remote operations and improved image interpretation.

    • What is Siemens Healthineers' approach toward technology in ultrasound care?

      Siemens Healthineers focuses on practical AI solutions to make ultrasound operations smarter and more efficient, with a goal of increasing access to high-quality imaging across various healthcare settings.

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    1/9/2026$92.00Overweight
    KeyBanc Capital Markets
    6/13/2025$69.00Buy
    B. Riley Securities
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $RDNT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by RadNet Inc.

    SCHEDULE 13G/A - RadNet, Inc. (0000790526) (Subject)

    3/27/26 11:35:46 AM ET
    $RDNT
    Medical Specialities
    Health Care

    SEC Form 10-K filed by RadNet Inc.

    10-K - RadNet, Inc. (0000790526) (Filer)

    3/2/26 5:17:51 PM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - RadNet, Inc. (0000790526) (Filer)

    3/2/26 7:01:44 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sorensen Alma Gregory

    4 - RadNet, Inc. (0000790526) (Issuer)

    3/23/26 4:15:05 PM ET
    $RDNT
    Medical Specialities
    Health Care

    SEC Form 4 filed by Sorensen Alma Gregory

    4 - RadNet, Inc. (0000790526) (Issuer)

    3/18/26 7:38:51 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Chief Strategy Officer Sorensen Alma Gregory converted options into 62,964 shares, increasing direct ownership by 5% to 1,244,842 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    3/12/26 5:52:02 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RadNet, Inc. to Present Today at the KeyBanc Capital Markets Healthcare Forum

    LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). There will be simultaneous and archived webcasts available at https://wsw.com/webcast/key40/rdnt/1686072 About RadNet, Inc.RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of

    3/17/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th

    LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12, 2026 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). There will be simultaneous and archived webcasts available at https://urldefense.com/v3/__https://cc.webcasts.com/barc002/031026a_js/?entity=144_X3VLDEI__;!!COmMWt7_Sw!XlHi2Z0Y8oljWTGFQhCAlqx-WUpj99UPNp1_sposW-TqahO41Keizcqhw9B4eULlXCe9bGpTDgrQlnQ9cI0$ Det

    3/11/26 4:15:00 PM ET
    $RDNT
    Medical Specialities
    Health Care

    DeepHealth Unveils Industry's Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026

    VIENNA, March 04, 2026 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ:RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of native clinical AI solutions and services across all core imaging modalities — MR, CT, X-ray, Mammography and Ultrasound — and spanning detection, assessment and monitoring, all available on one platform. With this week's acquisition of Gleamer, DeepHealth further expands its leadership in advancing screening tools into routine imaging and acute diagnostic care, uniquely positioned to deliver the next era of AI-powered health informatics.  "As European na

    3/4/26 7:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on RadNet with a new price target

    KeyBanc Capital Markets initiated coverage of RadNet with a rating of Overweight and set a new price target of $92.00

    1/9/26 9:07:04 AM ET
    $RDNT
    Medical Specialities
    Health Care

    B. Riley Securities initiated coverage on RadNet with a new price target

    B. Riley Securities initiated coverage of RadNet with a rating of Buy and set a new price target of $69.00

    6/13/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet upgraded by Raymond James with a new price target

    Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

    3/5/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Announces Addition of Board Member Mark Stolper

    CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute's board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ:RDNT), a position he has held since 2004. Mr. Stolper has also been a member of the Board of Directors of various publicly traded and privately held healthcare companies, including 21st Century Oncolog

    1/5/26 8:30:00 AM ET
    $RDNT
    $TOI
    Medical Specialities
    Health Care
    Medical/Nursing Services

    RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

    Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

    9/12/24 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/12/24 4:51:53 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/4/24 1:22:38 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    10/24/24 6:36:21 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Financials

    Live finance-specific insights

    View All

    RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS

    LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet's Digital Health strategy. On the call, investors will also have the opportunity to ask questions of executive management. Investor Call Details: The conference call will take place at 7:30 a.m. Pacific Time/10:30 am. Eastern Time/4:30 p.m. Centr

    3/4/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance

    Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compared with $75.0 million in the fourth quarter of 2024, an increase of 16.9%; Digital Health reportable segment Adjusted EBITDA(1) increased 8.9% to $4.9 million in the fourth quarter of 2025 from $4.5 million in the fourth quarter of

    3/2/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Acquires Gleamer, Making RadNet's DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide

    Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for musculoskeletal, breast, lung and neurologic applications.Gleamer's leadership in routine imaging, and particularly X-ray, is unparalleled through the breadth and scale of its cloud-first AI solutions. DeepHealth, combined with Gleamer's solutions will provide the industry's most comprehensive portfolio of native clinical AI solutions and services across all core imaging modalities. Gleamer achieved an Annual Recurring Revenue ("ARR") i compound annual growth rate exceeding 90% from 2022 through 2025 and is expected to reach approximately $30 millio

    3/2/26 5:45:00 AM ET
    $RDNT
    Medical Specialities
    Health Care